1. Home
  2. HMR vs QTTB Comparison

HMR vs QTTB Comparison

Compare HMR & QTTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

HMR

Heidmar Maritime Holdings Corp.

HOLD

Current Price

$1.08

Market Cap

90.3M

ML Signal

HOLD

Logo Q32 Bio Inc.

QTTB

Q32 Bio Inc.

HOLD

Current Price

$11.16

Market Cap

97.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HMR
QTTB
Founded
1984
2015
Country
Greece
United States
Employees
52
N/A
Industry
Marine Transportation
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
90.3M
97.5M
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
HMR
QTTB
Price
$1.08
$11.16
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$3.00
$13.00
AVG Volume (30 Days)
133.7K
350.0K
Earning Date
06-09-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
136.78
EPS
N/A
N/A
Revenue
N/A
$53,737,000.00
Revenue This Year
$64.04
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.73
$1.57
52 Week High
$1.71
$15.02

Technical Indicators

Market Signals
Indicator
HMR
QTTB
Relative Strength Index (RSI) 43.70 46.44
Support Level $0.81 $10.55
Resistance Level $1.29 $14.93
Average True Range (ATR) 0.10 1.50
MACD -0.02 -0.27
Stochastic Oscillator 22.19 15.77

Price Performance

Historical Comparison
HMR
QTTB

About HMR Heidmar Maritime Holdings Corp.

Heidmar Maritime Holdings Corp is a commercial and technical management company that operates tanker and dry-bulk vessel pools. The group, along with its subsidiaries, operates as a growing tanker pool company engaged in the commercial management and chartering of crude oil and refined petroleum product tankers. Its lines of business currently include asset management, tanker pooling, commercial and time charters, assisting clients with the buying and selling of ships, and technical management services for individual vessels, which include assistance in technical operations and crewing of the vessel. Its geographic areas are Singapore, the USA, the Marshall Islands, the United Arab Emirates, Germany, Switzerland, and Other.

About QTTB Q32 Bio Inc.

Q32 Bio Inc is a clinical-stage biotechnology company focused on developing novel biologics to restore healthy immune balance in patients with alopecia areata (AA) and other autoimmune and inflammatory diseases driven by immune dysfunction. Its product candidate, bempikibart (ADX 914), is a fully human anti-interleukin 7 receptor alpha (IL-7R) antagonist monoclonal antibody designed to block signaling mediated by interleukin 7 (IL 7) and thymic stromal lymphopoietin (TSLP) and re-regulate adaptive immune function. The company has completed two Phase 2a clinical trials evaluating bempikibart, SIGNAL AA Part A for the treatment of alopecia areata and SIGNAL AD for the treatment of atopic dermatitis (AD).

Share on Social Networks: